949 results match your criteria: "Hyperviscosity Syndrome"

Blood viscosity is the defining health indicator for hyperviscosity syndrome patients. This paper introduces an alternative approach for the real-time monitoring of blood viscosity by employing a surface-horizontal surface acoustic wave (SH-SAW) device at room temperature. A novel bi-layer waveguide is constructed on top of the SAW device.

View Article and Find Full Text PDF

PARACENTRAL ACUTE MIDDLE MACULOPATHY AS AN EARLY SIGN OF WALDENSTRÖM MACROGLOBULINEMIA.

Retin Cases Brief Rep

July 2023

Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon. Dr. Scruggs is now with the Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

Purpose: To report a case of paracentral acute middle maculopathy as the earliest sign of an undiagnosed, life-threatening hyperviscosity syndrome.

Methods: A 78-year-old man with an acute paracentral scotoma and examination findings of bilateral arteriolar tortuosity and unilateral paracentral acute middle maculopathy.

Results: Work-up revealed anemia and elevated serum viscosity.

View Article and Find Full Text PDF

Purpose: To report a case of bilateral exudative retinal detachments and panuveitis in a patient with multiple myeloma (MM).

Case Report: A 54-year-old patient with non-proliferative diabetic retinopathy was referred with blurred vision and scotomas in both eyes (OU). Three months prior to the onset of ocular symptoms, he was diagnosed with systemic MM and was receiving chemotherapy.

View Article and Find Full Text PDF

Lymphoplasmacytic lymphoma (LPL) is a neoplasm of small B lymphocytes, plasmacytoid lymphocytes and plasma cells usually involving the bone marrow (BM). A subset of LPL which is associated with IgM monoclonal gammopathy is called Waldenstrom's macroglobulinaemia (WM), and usually requires therapeutic intervention when a patient becomes symptomatic (Bone Marrow failure characterised by cytopenia or hyperviscosity syndrome). Here, we report the case of an 80-year-old female with clinically unsuspected WM who initially presented to the Emergency Department (ED) with nausea and vomiting.

View Article and Find Full Text PDF
Article Synopsis
  • The Consensus Panel 1 (CP1) of IWWM-11 focused on updating guidelines for managing symptomatic, treatment-naïve Waldenstrom's Macroglobulinemia (WM) patients, asserting that watchful waiting is best for asymptomatic cases.
  • Current first-line treatments include chemoimmunotherapy regimens like DRC and Benda-R, which are effective, usually well-tolerated, and cost-effective; covalent BTK inhibitors like zanubrutinib also provide a viable alternative, showing fewer side effects and better remissions compared to ibrutinib.
  • The panel also noted the importance of testing for MYD88 and CXCR4 mutations prior to treatment, as these can influence the effectiveness of certain
View Article and Find Full Text PDF
Article Synopsis
  • * Secondary causes of polycythemia, like kidney issues or smoking, were excluded, and he showed no signs of hyperviscosity syndrome.
  • * An ultrasound of the abdomen revealed no issues, but a JAK-2 mutation was found, confirming he has polycythemia vera (PV).
View Article and Find Full Text PDF

Background: Waldenström macroglobulinemia is a rare hematological malignancy and is the most common diagnosis in patients with hyperviscosity syndrome. Bilateral central retinal vein occlusion as an initial presentation of hyperviscosity syndrome in Waldenström macroglobulinemia is rare.

Case Presentation: A 42-year-old Nepalese male presented with sudden-onset bilateral painless blurring of vision.

View Article and Find Full Text PDF

The prevalence of cancer continues to grow globally every year. With therapeutic advances over the recent decades, the prevalence of individuals living with cancer continues to increase. Internal medicine residents can see patients admitted to the hospital for cancer-related emergencies.

View Article and Find Full Text PDF

A local-saturation-and-delay MRI method for evaluation of red blood cells aggregation for tumor-bearing or drug-used rats.

Front Bioeng Biotechnol

January 2023

State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Science-Wuhan National Laboratory for Optoelectronics, Wuhan, China.

Hyperviscosity syndrome (HVS) is a combination of clinical signs and symptoms related to increased blood viscosity. HVS can increase the thrombotic risk by causing a major disturbance to the blood flow, which is usually found in the advanced stages of the tumor. Moreover, some of the drugs used in chemotherapy, such as 5-fluorouracil and erythropoietin, are also capable of causing HVS through their respective pathways.

View Article and Find Full Text PDF

The unpredictable erythrocyte deformability alteration in some hematological disorders: How the classification of primary hyperviscosity syndromes could change.

Clin Hemorheol Microcirc

May 2023

Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.

According to Wells classification, it is possible to distinguish the primary hyperviscosity syndromes in polycythemic, sclerocythemic and sieric and/or plasmatic. In polycythemia vera, multiple myeloma, Waldenström's macroglobulinemia, and monoclonal gammopathy of undetermined significance, we have observed an unexpected behaviour of the erythrocyte deformability. This data highlights that the hemorheological alteration present in polycythemia vera has not been related to the increase of RBC mass only, as well as that present in plasmacellular dyscrasias has not been attributable to the increase of plasma viscosity only.

View Article and Find Full Text PDF

Hyperviscosity syndrome revisited.

Ann Pediatr Cardiol

November 2022

Department of Pediatric Cardiology, Narayana Superspecialty Hospital, Howrah, West Bengal, India.

Secondary erythrocytosis occurs in cyanotic heart disease as a physiological response to chronic hypoxia, and this leads to hyperviscosity and various complications of the same. Microvascular stasis due to hyperviscosity results in symptoms including headache, fatigue, paraesthesia, and loss of vision. An important and dreadful feature of hyperviscosity is overt thrombosis in organ systems, resulting in cerebrovascular accident and myocardial infarction.

View Article and Find Full Text PDF

Hyperviscosity syndrome (HVS) is a rare complication of newly diagnosed multiple myeloma (NDMM) related to high tumour burden. Studies about the prognosis of HVS in modern-era therapy for NDMM are missing. We investigated a retrospective cohort study of NDMM with HVS between 2011-2021.

View Article and Find Full Text PDF

Hyperviscosity syndrome (HVS) is an infrequent but life-threatening complication of multiple myeloma (MM) and classically presents with the triad of mucosal bleed, neurological, and visual disturbances. HVS is typically associated with immunoglobulin M (IgM) MM and very rarely may complicate immunoglobulin G (IgG) MM. Even suspicion of HVS necessitates therapy based on clinical severity rather than the calculated degree of viscosity.

View Article and Find Full Text PDF

COVID-19 Demonstrates That Inflammation Is a Hyperviscous State.

Cureus

October 2022

Cardiac/Thoracic/Vascular Surgery, Jacqmar, Inc., Minneapolis, USA.

Article Synopsis
  • Many complications of severe COVID-19 stem from blood hyperviscosity, primarily due to high fibrinogen levels, which leads to a unique syndrome affecting blood flow in various areas of the body.
  • Elevated blood viscosity can increase the risk of thrombosis and decrease the perfusion of vital organs, resulting in issues like silent hypoxemia in the lungs and diastolic dysfunction in the heart.
  • The virus responsible for COVID-19 has specific genetic factors that hyperactivate the immune response, contributing to high fibrinogen levels and complications such as endothelial damage and persistent symptoms in long-COVID patients.
View Article and Find Full Text PDF

Aims: Rheopheresis is an extracorporeal haematotherapy that improves haemorheological status by filtering proteins that enhance blood viscosity. It also has anti-inflammatory effects by removing inflammatory cytokines. Our study aims to examine the effects of rheopheresis on the endothelial status in diabetic lower extremity ulceration.

View Article and Find Full Text PDF
Article Synopsis
  • Hypereosinophilic syndrome (HES) is a rare condition characterized by high eosinophil levels that can damage various tissues, leading to serious complications like stroke in 12% of patients.
  • The main treatment goal is to lower eosinophil counts and reduce their duration in tissues, often supported by the use of anticoagulants.
  • A reported case illustrates that timely diagnosis and proper treatment can significantly minimize tissue damage and preserve functionality in patients suffering from HES.
View Article and Find Full Text PDF

Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver Failure.

JACC Case Rep

October 2022

Metabolism and Lipids Unit, Cardiovascular Institute, Marie-Josee and Henry R Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York, USA.

We describe a case referred for worsening hypercholesterolemia in the setting of atorvastatin and fenofibrate-induced liver injury. The patient reported neurological complaints attributed to hyperviscosity syndrome (induced by lipoprotein-X and lipoprotein-Z). Hepatic recovery was associated with reduction of whole blood viscosity and amelioration of neurological symptoms.

View Article and Find Full Text PDF

Symmetrical peripheral gangrene (SPG) is a rare clinical syndrome characterized by an acute onset of ischemic damage in two or more extremities without obstruction or vasculitis of supplying vessels. Body parts commonly affected include toes, hands, scrotum, and earlobes, increasing the risk of limb amputation and impairing the quality of life. The vascular injury mechanism is disseminated intravascular coagulation.

View Article and Find Full Text PDF

CRYOGLOBULINEMIC VASCULITIS.

J Emerg Med

September 2022

John H. Stroger Jr., Hospital of Cook County, Department of Emergency Medicine, Chicago, Illinois.

Background: Cryoglobulinemia is a hematologic condition characterized by the presence of immunologic proteins in the blood, resulting from underlying malignancy to chronic viral processes. The recognition of this condition is critically vital, as patients can first present to the emergency department as their initial manifestation of disease.

Case Report: We present a case of cryoglobulinemia, discuss the clinically important types, their presentations, and then emergent complications that can be encountered in the emergency setting.

View Article and Find Full Text PDF

Bilateral Central Retinal Vein Occlusion as a First Presentation of Multiple Myeloma: A Case Report.

Clin Pract Cases Emerg Med

August 2022

Northwestern University, Feinberg School of Medicine, Department of Emergency Medicine, Chicago, Illinois.

Introduction: Acute presentation of multiple myeloma in the emergency department (ED) is an uncommon yet life-threatening clinical entity.

Case Report: A 42-year-old male presented to the ED with severe generalized fatigue and vision changes most notable in his left eye. Bilateral central retinal vein occlusion (CRVO) was diagnosed on dilated fundus exam in the ED.

View Article and Find Full Text PDF

Purpose: The following case report highlights a rare presentation of chronic myeloid leukemia-associated hyper-viscosity syndrome and provides a brief review of expected findings and treatment outcomes.

Methods: An otherwise healthy 27-year-old woman presented to the ophthalmology clinic with mild bilateral blurriness (20/20 in both eyes) and prolonged light adaption in the morning for several months. Examination demonstrated severe bilateral venous stasis, white-centered hemorrhages, intraretinal hemorrhage, and peripheral ischemia with diffuse leakage.

View Article and Find Full Text PDF

Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices.

Curr Opin Hematol

November 2022

Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine.

Purpose Of Review: Hyperviscosity syndromes can lead to significant morbidity and mortality. Existing methods to measure microcirculatory rheology are not readily available and limited in relevance and accuracy at this level. In this review, we review selected hyperviscosity syndromes and the advancement of their knowledge using microfluidic platforms.

View Article and Find Full Text PDF

Acquired von Willebrand syndrome (aVWS) develops with various underlying diseases. We herein report an individual with aVWS associated with mucosa-associated lymphoid tissue lymphoma in the lungs complicated by hyperviscosity syndrome, Sjögren's syndrome, and hypothyroidism. This patient developed life-threatening hemorrhaging during a lung biopsy despite transfusion of concentrate of plasma-derived VWF/factor VIII.

View Article and Find Full Text PDF

The incidence of hematologic malignancies is on the rise worldwide. Kidney disease is ubiquitous in patients with hematologic malignancies, encompassing a wide spectrum of disorders involving each kidney compartment, including the vasculature, tubules, interstitium, and glomerulus, and there is significant overlap of kidney involvement with each hematologic malignancy. Vascular disorders include both microvascular and macrovascular damage, via thrombotic microangiopathy, hyperleukocytosis, hyperviscosity, and cryoglobulinemia.

View Article and Find Full Text PDF